MedDataX Logo

Clinical Study to Compare Dental Plaque Control

NCT ID: NCT00758394

Last Updated: 2013-08-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical study was to evaluate the control of dental plaque formation after toothbrushing for 4 days with each of the 4 study toothpastes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation of dental plaque control for two prototype toothpastes will be determined by comparison to two control toothpastes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Plaque

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fluoride - A

Fluoride only toothpaste

Group Type PLACEBO_COMPARATOR

Fluoride

Intervention Type DRUG

Brush two times a day for 4 days.

Total + Whitening toothpaste - B

Triclosan/fluoride toothpaste

Group Type ACTIVE_COMPARATOR

Triclosan/Fluoride

Intervention Type DRUG

Brush two times daily for 4 days

Triclosan/fluoride/Amino Acid - C

toothpaste containing amino acid #1

Group Type EXPERIMENTAL

Triclosan/Fluoride

Intervention Type DRUG

Brush twice daily for 4 days

Triclosan/fluoride/Cavistat -D

toothpaste containing amino acid/bicarbonate

Group Type EXPERIMENTAL

Triclosan/Fluoride

Intervention Type DRUG

Brush twice daily for 4 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluoride

Brush two times a day for 4 days.

Intervention Type DRUG

Triclosan/Fluoride

Brush two times daily for 4 days

Intervention Type DRUG

Triclosan/Fluoride

Brush twice daily for 4 days

Intervention Type DRUG

Triclosan/Fluoride

Brush twice daily for 4 days

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

monofluorophosphate sodium fluoride triclosan sodium fluoride triclosan amino acid sodium fluoride triclosan amino acid/bicarbonate

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female volunteers at least 18 - 53 years of age
* Good general health
* Must sign informed consent form
* Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
* No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion Criteria

* Subjects unable or unwilling to sign the informed consent form.
* Medical condition which requires pre-medication prior to dental visits/procedures
* Moderate or advanced periodontal disease or heavy dental tartar (calculus).
* 2 or more decayed untreated dental sites at screening.
* Other disease of the hard or soft oral tissues.
* Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
* Use of medications that are currently affecting salivary function
* Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
* Pregnant or nursing women.
* Participation in any other clinical study within 1 week prior to enrollment into this study.
* Use of tobacco products
* Subjects who must receive dental treatment during the study dates.
* Current use of Antibiotics for any purpose.
* Presence of an orthodontic appliance which interferes with plaque scoring.
* History of allergy to common dentifrice ingredients.
* History of allergy to arginine (amino acid)
* History of allergy to bicarbonate
* Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)
Minimum Eligible Age

18 Years

Maximum Eligible Age

53 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Colgate Palmolive

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Colgate Palmolive

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patricia Corby, DDS

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bluestone Center for Clinical Research, NYU College of Dentistry

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRO-0907-PLA-14-RR

Identifier Type: -

Identifier Source: org_study_id